Covid Update
|
5
|
Resverlogix Corp.
|
Jun 10, 2022 02:23PM
|
Covid still alive
|
7
|
Resverlogix Corp.
|
Mar 13, 2022 06:19PM
|
Covid Opportunity or Challenge for RVX
|
8
|
Resverlogix Corp.
|
Jun 14, 2022 07:40PM
|
Covid China
|
5
|
Resverlogix Corp.
|
Mar 28, 2022 05:33PM
|
Covid
|
6
|
Resverlogix Corp.
|
Aug 12, 2022 12:09PM
|
Corporate Year ends
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 07:01PM
|
Consequences of BETonMACE Findings
|
1
|
Resverlogix Corp.
|
May 10, 2016 01:26PM
|
Congrats
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 11:39AM
|
Confused
|
7
|
Zenith Epigenetics
|
Dec 18, 2015 07:28PM
|
Competition
|
3
|
Resverlogix Corp.
|
Nov 28, 2021 11:28AM
|
Compensation Commity
|
2
|
Resverlogix Corp.
|
Mar 26, 2021 05:30PM
|
Club or Business
|
9
|
Resverlogix Corp.
|
Apr 17, 2022 11:59AM
|
Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 20, 2019 02:12PM
|
Christmas Wish List
|
6
|
Resverlogix Corp.
|
Dec 01, 2021 11:19AM
|
CHIP and heart attacks and strokes - inflammation
|
3
|
Resverlogix Corp.
|
Feb 04, 2018 03:35PM
|
Chinese Perspective
|
4
|
Resverlogix Corp.
|
Jun 08, 2015 09:17AM
|
China on IV by rndtbl
|
1
|
Resverlogix Corp.
|
Jan 31, 2018 03:27PM
|
Change in Auditors
|
3
|
Resverlogix Corp.
|
Mar 08, 2023 11:35AM
|
CEPT and BP
|
6
|
Resverlogix Corp.
|
Sep 04, 2017 11:19AM
|
CEO Compensation
|
9
|
Resverlogix Corp.
|
Oct 18, 2022 02:05PM
|